Literature DB >> 3326036

High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development.

J K Nicholson, I D Wilson.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3326036     DOI： 10.1007/978-3-0348-9289-6_13

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  9 in total

Review 1.  NMR studies of drug metabolism and disposition.

Authors:  J D Bell; D G Gadian; N E Preece
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Uses and limitations of nuclear magnetic resonance (NMR) spectroscopy in clinical pharmacokinetics.

Authors:  M C Malet-Martino; R Martino
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

4.  Comparative study on effects of Xiaoyao Powder and its modified prescription on plasma metabolomics of rats with chronic immobilization stress.

Authors:  He-Gu Luo; Jia-Xu Chen; Qi Zhang; Guang-Xin Yue; Jie Ding; Han-Ting Zhang; Xian-Zhong Yan; Xin Zhao; Zhen-Zhi Meng
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

5.  Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat.

Authors:  K P Gartland; F W Bonner; J A Timbrell; J K Nicholson
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 6.  Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Authors:  R E Kauffman; G L Kearns
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

7.  Hepatotoxin-induced hypertaurinuria: a proton NMR study.

Authors:  S M Sanins; J K Nicholson; C Elcombe; J A Timbrell
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

8.  Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo.

Authors:  S M Sanins; J A Timbrell; C Elcombe; J K Nicholson
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

9.  The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study.

Authors:  Billy Molloy; Lauren Mullin; Adam King; Lee A Gethings; Robert S Plumb; Ian D Wilson
Journal:  Metabolites       Date:  2021-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.